Though the clinical significance of PINK1–Parkin signalling is incontrovertible, the contribution of this pathway to mitophagy in vivo remains unclear, as does the contribution of dysregulated mitophagy to PD [66]. The gene discussed is PRKN; the disease is Parkinson disease.